Also trades as: BFRI (NASDAQ) · $vol 0M
BFRIW NASDAQ
Biofrontera Inc.
1W: -66.2%
1M: -72.5%
3M: -89.2%
YTD: -92.0%
1Y: -93.5%
3Y: -99.5%
$0.01
-0.00 (-30.61%)
Weekly Expected Move ±28.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$42M
+11.8% ▲
5Y CAGR: +17.2%
Gross Profit
$32M
+69.0% ▲
5Y CAGR: +26.4%
Operating Income
-$11M
+34.1% ▲
Net Income
-$11M
+40.7% ▲
EPS (Diluted)
$-0.90
+72.0% ▲
EBITDA
-$10M
+27.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $24M | $29M | $34M | $37M | $42M |
| YoY Growth | +27.9% | +19.0% | +18.8% | +9.5% | +11.8% |
| Cost of Revenue | $13M | $15M | $17M | $19M | $10M |
| Gross Profit | $11M | $13M | $17M | $19M | $32M |
| Gross Margin | 47.1% | 47.0% | 48.8% | 50.1% | 75.8% |
| R&D Expenses | $0 | $0 | $77K | $2M | $4M |
| SG&A Expenses | $37M | $36M | $39M | $34M | $38M |
| Operating Expenses | $37M | $32M | $39M | $36M | $43M |
| Operating Income | -$25M | -$19M | -$23M | -$17M | -$11M |
| Operating Margin | -104.6% | -64.8% | -66.6% | -46.1% | -27.2% |
| Interest Expense | $360K | $370K | $600K | $2M | $452K |
| Income Before Tax | -$38M | -$608K | -$20M | -$18M | -$11M |
| Tax Expense | $56K | $32K | $14K | $22K | $25K |
| Net Income | -$38M | -$640K | -$20M | -$18M | -$11M |
| Net Margin | -156.5% | -2.2% | -59.1% | -47.6% | -25.3% |
| EPS (Diluted) | $-44.10 | $-0.61 | $-13.02 | $-3.22 | $-0.90 |
| EBITDA | -$37M | $934K | -$18M | -$14M | -$10M |
| Shares Outstanding | 855237 | 1M | 2M | 6M | 12M |